Literature DB >> 32482963

Tear Opiorphin Levels in Ocular Pain Caused by Corneal Foreign Body.

Sibel Ozdogan1, Cigdem Sonmez2, Demet Yolcu1, Mustafa Gungormus3.   

Abstract

PURPOSE: Opiorphin is an endogenous inhibitor of enkephalin-degrading enzymes. It has a strong analgesic effect in chemical and mechanical pain models. We aimed to evaluate the tear opiorphin levels in ocular pain caused by corneal foreign bodies and demonstrate whether there is any correlation with pain levels obtained from the Visual Analog Scale (VAS) score and tear opiorphin level.
METHODS: Thirty-two healthy individuals and 34 individuals diagnosed with corneal foreign bodies were included in this study. Tear opiorphin levels were measured by the ELISA method using a commercially available kit. The difference in tear opiorphin levels between the patient and control groups were evaluated using the Mann-Whitney U test. The correlation between VAS scores and tear opiorphin levels was evaluated using the Spearman rank correlation coefficient.
RESULTS: The median values of tear opiorphin levels of the patient and control groups were 134 pg/mL (86.86-296.25) and 109.80 pg/mL (66.15-191.49), respectively. The Mann-Whitney U test showed a statistically significant difference in tear opiorphin levels between patient and control groups (P < 0.05). No ocular pain was reported in the control group. The median VAS score of the patient group was 6 points (1-9). No correlation was found between VAS scores and tear opiorphin levels in the patient group.
CONCLUSIONS: The cornea is the most densely innervated tissue, and the highest opiorphin concentrations have been observed in tear. It is, therefore, expected that the stimulation or damage to the nerve endings in cornea would cause an increase in opiorphin secretion as a pain relief mechanism.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32482963     DOI: 10.1097/ICO.0000000000002383

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

Review 1.  New Perspectives in the Pathophysiology and Treatment of Pain in Patients with Dry Eye Disease.

Authors:  Giuseppe Giannaccare; Carla Ghelardini; Alessandra Mancini; Vincenzo Scorcia; Lorenzo Di Cesare Mannelli
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

Review 2.  Topical Therapeutic Options in Corneal Neuropathic Pain.

Authors:  Jeremy Nortey; David Smith; Gerami D Seitzman; John A Gonzales
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

3.  Expression of salivary immunoglobulins and their association with analgesic neuropeptide opiorphin in anorexia nervosa during adolescence.

Authors:  Elzbieta Paszynska; Amadeusz Hernik; Agnieszka Slopien; Yves Boucher; Marta Tyszkiewicz-Nwafor; Magdalena Roszak; Karolina Bilska; Monika Dmitrzak-Weglarz
Journal:  J Eat Disord       Date:  2022-08-11

4.  GlicoPro, Novel Standardized and Sterile Snail Mucus Extract for Multi-Modulative Ocular Formulations: New Perspective in Dry Eye Disease Management.

Authors:  Rita Mencucci; Giovanni Strazzabosco; Virginia Cristofori; Andrea Alogna; Daria Bortolotti; Roberta Gafà; Michela Cennamo; Eleonora Favuzza; Claudio Trapella; Valentina Gentili; Roberta Rizzo
Journal:  Pharmaceutics       Date:  2021-12-13       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.